Follow
Szymon Pach
Title
Cited by
Cited by
Year
Next generation 3D pharmacophore modeling
D Schaller, D Šribar, T Noonan, L Deng, TN Nguyen, S Pach, D Machalz, ...
Wiley Interdisciplinary Reviews: Computational Molecular Science 10 (4), e1468, 2020
1692020
PyRod: Tracing water molecules in molecular dynamics simulations
D Schaller, S Pach, G Wolber
Journal of chemical information and modeling 59 (6), 2818-2829, 2019
232019
Structural insights into understudied human cytochrome P450 enzymes
D Machalz, S Pach, M Bermudez, M Bureik, G Wolber
Drug discovery today 26 (10), 2456-2464, 2021
222021
Catching a moving target: comparative modeling of flaviviral NS2B-NS3 reveals small molecule Zika protease inhibitors
S Pach, TM Sarter, R Yousef, D Schaller, S Bergemann, C Arkona, ...
ACS Medicinal Chemistry Letters 11 (4), 514-520, 2020
142020
ACE2-variants indicate potential SARS-CoV-2-susceptibility in animals: an extensive molecular dynamics study
S Pach, TN Nguyen, J Trimpert, D Kunec, N Osterrieder, G Wolber
bioRxiv, 2020.05. 14.092767, 2020
122020
Chemical Evolution of Antivirals Against Enterovirus D68 through Protein‐Templated Knoevenagel Reactions
C Tauber, R Wamser, C Arkona, M Tügend, UB Abdul Aziz, S Pach, ...
Angewandte Chemie International Edition 60 (24), 13294-13301, 2021
102021
A benzoxazole derivative as an inhibitor of anaerobic choline metabolism by human gut microbiota
MT Gabr, D Machalz, S Pach, G Wolber
RSC Medicinal Chemistry 11 (12), 1402-1412, 2020
82020
In vitro, in vivo and in silico characterization of a novel kappa-opioid receptor antagonist
K Puls, AL Olivé-Marti, S Pach, B Pinter, F Erli, G Wolber, M Spetea
Pharmaceuticals 15 (6), 680, 2022
62022
ACE2‐Variants Indicate Potential SARS‐CoV‐2‐Susceptibility in Animals: A Molecular Dynamics Study
S Pach, TN Nguyen, J Trimpert, D Kunec, N Osterrieder, G Wolber
Molecular Informatics 40 (9), 2100031, 2021
62021
Discovery of Small-Molecule TIM-3 Inhibitors for Acute Myeloid Leukemia Using Pharmacophore-Based Virtual Screening
SA Abdel-Rahman, V Talagayev, S Pach, G Wolber, MT Gabr
Journal of Medicinal Chemistry 66 (16), 11464-11475, 2023
32023
A Critical Study on Acylating and Covalent Reversible Fragment Inhibitors of SARS‐CoV‐2 Main Protease Targeting the S1 Site with Pyridine
R Wamser, S Pach, C Arkona, M Baumgardt, UBA Aziz, AC Hocke, ...
ChemMedChem 18 (9), e202200635, 2023
22023
Discovery of ICOS‐Targeted Small Molecules Using Pharmacophore‐Based Screening
L Calvo‐Barreiro, V Talagayev, S Pach, SA Abdel‐Rahman, G Wolber, ...
ChemMedChem 18 (23), e202300305, 2023
12023
Exploiting Water Dynamics for Pharmacophore Screening
D Schaller, S Pach, M Bermudez, G Wolber
Protein-Ligand Interactions and Drug Design, 227-238, 2021
12021
Crystal structures of glycoprotein D of equine alphaherpesviruses reveal potential binding sites to the entry receptor MHC-I
V Kremling, B Loll, S Pach, I Dahmani, C Weise, G Wolber, S Chiantia, ...
Frontiers in microbiology 14, 1197120, 2023
2023
Mechanistic Elucidation of Protease–Substrate and Protein–Protein Interactions for Targeting Viral Infections
S Pach
2022
Chemische Evolution antiviraler Wirkstoffe gegen Enterovirus D68 durch Proteintemplat‐gesteuerte Knoevenagelreaktionen
C Tauber, R Wamser, C Arkona, M Tügend, UB Abdul Aziz, S Pach, ...
Angewandte Chemie 133 (24), 13405-13413, 2021
2021
ACE2-Variants Indicate Potential SARS-CoV-2-Susceptibility in Animals: An Extensive Molecular Dynamics Study (preprint)
S Pach, TN Nguyen, J Trimpert, D Kunec, N Osterrieder, G Wolber
2020
The system can't perform the operation now. Try again later.
Articles 1–17